* IRIDEX Corp IRIX.OQ IRIX.O is expected to show a rise in
quarterly revenue when it reports results on August 12.
* The Mountain View, California-based company is expected to
report a 86.7% increase in revenue to $11.609 million from
$6.22 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for IRIDEX Corp is for a
loss of 15 cents per share. For the same quarter last year, the
company reported a loss of 20 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for IRIDEX Corp is
$10.5, about 37.4% above its last closing price of $6.57.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.14 -0.14 -0.14 Met 0
Dec. 31 2020 -0.11 -0.10 -0.01 Beat 90.5
Sep. 30 2020 -0.17 -0.17 -0.12 Beat 31.4
Jun. 30 2020 -0.22 -0.22 -0.20 Beat 11.1
Mar. -0.17 -0.16 -0.12 Beat 27.3
31 2020
Dec. 31 2019 -0.15 -0.11 Beat 29
Sep. 30 2019 -0.17 -0.17 -0.13 Beat 25.7
Jun. 30 2019 -0.22 -0.22 -0.18 Beat 18.2
This summary was machine generated August 10 at 21:35 GMT. All
figures in US dollars unless otherwise stated